Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal by Sylla Thiam et al.
Thiam et al. Malaria Journal 2012, 11:334
http://www.malariajournal.com/content/11/1/334RESEARCH Open AccessScale-up of home-based management of
malaria based on rapid diagnostic tests and
artemisinin-based combination therapy in a
resource-poor country: results in Senegal
Sylla Thiam1, Julie Thwing2*, Ibrahima Diallo3, Fatou B Fall3, Mame B Diouf3, Robert Perry2, Medoune Ndiop3,
Mamadou L Diouf3, Moustapha M Cisse3, Mamadou M Diaw4 and Moussa Thior3Abstract
Background: Effective case management of malaria requires prompt diagnosis and treatment within 24 hours.
Home-based management of malaria (HMM) improves access to treatment for populations with limited access to
health facilities. In Senegal, an HMM pilot study in 2008 demonstrated the feasibility of integrated use of RDTs and
ACT in remote villages by volunteer Home Care Providers (HCP). Scale-up of the strategy began in 2009, reaching
408 villages in 2009 and 861 villages in 2010. This paper reports the results of the scale-up in the targeted
communities and the impact of the strategy on malaria in the formal health sector.
Methods: Data reported by the HCPs were used to assess their performance in 2009 and 2010, while routine
malaria morbidity and mortality data were used to assess the impact of the HMM programme. Two high
transmission regions where HMM was not implemented until 2010 were used as a comparison.
Results and discussion: From July 2009 through May 2010, 12582 suspected cases were managed by HCPs, 93%
(11672) of whom were tested with an RDT. Among those tested, 37% (4270) had a positive RDT, 97% (4126) of
whom were reported treated and cured. Home care providers referred 6871 patients to health posts for
management: 6486 with a negative RDT, 119 infants < 2 months, 105 pregnant women, and 161 severe cases. There
were no deaths among these patients. In 2009 compared to 2008, incidence of suspected and confirmed malaria
cases, all hospitalizations and malaria-related hospitalizations decreased in both intervention and comparison
regions. Incidence of in-hospital deaths due to malaria decreased by 62.5% (95% CI 43.8-81.2) in the intervention
regions, while the decrease in comparison regions was smaller and not statistically significant.
Conclusion: Home-based management of malaria including diagnosis with RDT and treatment based on test
results is a promising strategy to improve the access of remote populations to prompt and effective management
of uncomplicated malaria and to decrease mortality due to malaria. When scaled-up to serve remote village
communities in the regions of Senegal with the highest malaria prevalence, home care providers demonstrated
excellent adherence to guidelines, potentially contributing to a decrease in hospital deaths attributed to malaria.
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Effective management of malaria cases requires prompt
diagnosis and effective treatment within 24 hours. Des-
pite the efforts made by countries to scale up
artemisinin-based combination therapy (ACT) and rapid
diagnostic tests (RDTs) in health facilities, most people
who are vulnerable to malaria live far from health facil-
ities and have limited access to diagnosis and treatment.
The lack of access to malaria services, particularly in re-
mote areas, is a barrier to early and appropriate malaria
case management, thereby leading to more complicated
disease and malaria-related deaths. More than 90% of
sick children in rural areas in Senegal receive their first
treatment at home. Unfortunately, most of the time, they
receive inappropriate self-medication [1].
Expanding malaria diagnosis and treatment is critical
to achieving universal access to case management mea-
sures and to eliminating deaths due to malaria by 2015.
The World Health Organization (WHO), therefore,
recommends home-based management of malaria
(HMM) as a means to increase access to prompt and ef-
fective treatment of malaria [2]. Bringing treatment
closer to home through the implementation of HMM
should improve access to malaria case management
services in areas with scarce health facilities and quali-
fied human resources, as is typically found in rural
Africa [3-5]. A number of studies, some of them con-
ducted under the leadership of the WHO, have demon-
strated its feasibility and efficacy [6-9], and several
studies have evaluated the introduction of ACT through
HMM programmes [10,11].Figure 1 Map of regions in which home-based management of malarThe introduction of malaria case management with
parasitological diagnosis adds a layer of complexity, with
questions as to the ability of community level volunteers
to adequately perform the RDTs and administer treat-
ment according to test results. Recently, successful intro-
duction of RDTs into HMM programmes has been
reported in several African countries [12-17]. However,
most of these studies are pilot experiences implemented
in limited areas and targeted only children under five.
Thus the interventions did not reach all vulnerable
populations, particularly within the context of universal
access to diagnosis and treatment, and did not maximize
public health impact.
In Senegal, case management of malaria in public
health facilities was scaled up nationwide with ACT in
2007 and RDTs in 2008 [18]. However, despite scaling
up ACT and RDTs in all public health facilities, chal-
lenges still existed relating to early and adequate care of
malaria cases in Senegal, particularly in rural areas with
limited access to health services. In 2008, an HMM pilot
study involving 20 villages located more than 5 km from
the nearest health facility, each with a volunteer home
care provider (HCP) trained to manage uncomplicated
malaria using RDTs and ACT, demonstrated the feasibil-
ity of integrated use of RDTs and ACT in the commu-
nity [14]. Based on encouraging results from the pilot
phase, the Ministry of Health decided to scale up HMM,
reaching in total 408 remote villages in 2009 and 861 re-
mote villages in 2010 [19].
Data reported by HCPs and district level reporting of
malaria morbidity and mortality were used to evaluateia was implemented, and the two comparison regions.
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of malaria using RDTs and ACT to provide case man-
agement based on parasitological diagnosis of malaria.
Methods
Setting
Senegal is a West African country where malaria is en-
demic, with a high transmission period during the rainy
season from July to November. The entire population is
at risk and Plasmodium falciparum accounts for 100%
of reported malaria cases [20]. In 2009, HMM was
scaled-up in 25 rural districts located in seven high
prevalence regions in southern and eastern Senegal with
high rates of malaria transmission and malaria-related
morality (Figure 1). The total population of the regions
in which HMM was introduced was 3,202,760 inhabi-
tants, though the population served by the HMM
programme was much smaller, with a typical village size
averaging 500 inhabitants. Scale up of the HMM strategy
commenced in January 2009, with selection of HCPs in
408 villages either located ≥5 km from the nearest health
facility or with difficulties accessing the closest health fa-
cility, either throughout the year or during the rainy sea-
son. Data recording began in July 2009, at the beginning
of malaria transmission season. During 2010, the add-
itional 453 villages were added prior to the malaria
transmission season, bringing the total number of vil-
lages to 861, the number of districts involved to 32, and
adding two additional high prevalence regions.
Intervention
Training
In each village a volunteer HCP able to read and write
was chosen by the community. They were trained on (i)
malaria case management using RDTs and artesunate-
amodiaquine, and (ii) referral of RDT negative patients,
those with severe disease, and all malaria cases in preg-
nant women and children less than two months and (iii)
collecting data using standardized tools. Job aids with a
clear algorithm were developed by the NMCP and used
by the HCPs to manage patients (Figure 2).
A cascade model was adopted to conduct trainings.
First, in each region all District Health Teams (DHTs)
and the regional health team received two days of train-
ing as trainers by the National Malaria Control
Programme (NMCP) personnel. The DHTs, supported
by the regional team and under the supervision of the
NMCP team, trained HCPs from their respective catch-
ment areas. The training process was conducted on the
basis of the revised manual of the pilot phase, and
involved two steps: a theoretical session during three
days, followed by two weeks of practical internship
supervised by the head nurse in the health facility serv-
ing the HCP’s village. This health facility providedsupervision and a link between the HCP and the formal
health system.
Drugs and supplies
SD Bioline Malaria Ag Pf RDT, an RDT meeting per-
formance criteria for WHO procurement recommenda-
tions [21], and having demonstrated good accuracy in
the field in Senegal [19] was used to test patients
with suspected malaria. Patients with a positive RDT
were treated with an artesunate-amodiaquine fixed dose
combination that had an efficacy and safety profile con-
firmed by a local research institution [22]. As recom-
mended by the national policy during the period of this
intervention, RDTs were performed free of charge. ACT
treatments cost USD 0.6 for adults and USD 0.3 for chil-
dren through April 2010 and since May 2010 have been
free of charge for all ages.
A supply and monitoring system was established and
drugs and supplies were provided by the supporting
health facility. Programme monitoring included post-
training follow up, monthly supervision by the health
post head nurse, and coordinating meetings carried out
by DHTs and the nurses in the peripheral health facil-
ities. Also, at regional level, biannual coordinating meet-
ings were held, involving all stakeholders in the region.
Incentives
While there were no monetary incentives and the HCP
worked as a volunteer, incentives included recognition
by receiving a certificate, job aids and equipment after
training, and an official launch organized by the local,
administrative and health authorities. In addition, the
HCPs received transport fees during regular meetings,
participated in mass campaigns of immunization and net
distribution, and received consultation free of charge in
health facilities when needed.
Participation, advocacy and communication
Local and administrative authorities as well as commu-
nity leaders were informed and involved, and both gov-
ernmental and non-governmental organizations played a
crucial role during the implementation. At the district
level, networks of local grassroots organizations that
assist DHTs in the implementation of community based-
interventions participated in training sessions and meet-
ings as well as advocacy and communication activities.
Sensitization meetings were organised by health workers
and community leaders in the selected villages, and
the implementation was supported by community
mobilization events and broadcasts on local radio sta-
tions. Lastly, the head of the village provided support to
the HCP and ensured the link between the community
and the HCP.
Negative RDT result Positive RDT result 
Condition improving Condition not improving 
Fever (hot body or fever during
the last 2 days)
Perform malaria RDT 
Refer patient to health
facility
Treatment with ACT
Follow up after 48 hours






Figure 2 Algorithm for case management of fever by HCPs.
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This evaluation was based on data collected both at
community level by the HCPs and at health facilities.
Most HCPs started reporting data in August 2009, and
data were available only through May 2010, effectively
limiting the analysis to the first few months of imple-
mentation (malaria transmission season of 2009).
At health facilities (hospitals, health centres and health
posts), routine malaria data are collected by health work-
ers using a standard form. They report on a monthly
basis to the district, where all data are validated andFigure 3 Total numbers of cases seen monthly by home care provide
through December 2009.aggregated before entry to the database (Epi Info Ver-
sion 6) and sent to the NMCP. The NMCP has imple-
mented a data quality assurance system at three stages:
first, all reports are validated by the upper level before
being submitted, second, a data quality assessment is
part of the supervision checklist on all levels including
HCPs, and lastly, on a quarterly basis the NMCP holds
review meetings with regional and DHTs and all district
data (from health facilities and community level) are
presented and validated. Finally, the aggregated data for
each district are entered into the national database.rs, rapid diagnostic tests performed, and test results: July
Table 1 Household possession and use of insecticide-treated nets in intervention and comparison regions in
December 2009*
Proportion of households
possessing at least one ITN
Proportion of children< 5 years
sleeping under an ITN
Proportion of the total population
sleeping under an ITN
% (95% CI) % (95% CI) % (95% CI)
Intervention regions
Fatick 96.7 (94.9-98.4) 60.2 (40.2-80.1) 52.2 (37.4 – 67.1)
Kaffrine 89.9 (84.3-95.5) 46.5 (23.3-69.7) 37.5 (17.0-58.1)
Kaolack 95.4 (93.0-97.9) 44.5 (32.4-56.7) 33.8 (23.5-44.0)
Kédougou 87.0 (82.4-91.6) 41.1 (27.9-54.3) 30.4 (22.9-37.9)
Matam 84.0 (77.8-90.3) 58.6 (46.1-71.2) 45.8 (36.7-54.9)
Tambacounda 86.6 (82.3-91.0) 37.1 (26.8-47.5) 26.1 (19.5 – 32.7)
Comparison regions
Kolda 89.2 (84.3-94.1) 70.8 (63.0-78.5) 60.6 (56.1-65.1)
Sédhiou 90.2 (86.1-94.3) 66.2 (53.2-79.2) 53.0 (42.4-63.7)
*Regional level data from post-ITN distribution campaign survey in December 2009 [23].
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demographics, test results, treatment and follow up as
well as drug consumption and stock. The information
on this register was aggregated by the head nurse at the
health post, who prepared a monthly report for the
DHT. All of these reports were presented and validated
during the coordinating meetings. These data were not
integrated into the data from health facilities for the pur-
poses of this analysis.
Data reported by the HCPs were used to assess per-
formance in terms of diagnosis, treatment and referral in
2009 and 2010. Given the simultaneous scale-up of other
malaria control interventions including insecticide-
treated nets during the same period, it was necessary to
identify comparison regions similar in terms of malaria
transmission to evaluate impact at the health facility
level. The step-wise introduction of HMM, in the major-
ity of targeted regions in 2009, and in the remaining two
high transmission regions (Kolda and Sedhiou) in 2010
allowed for comparison of health facility data between
the regions in which HMM was introduced in 2009, and
the regions in which it was delayed until the following
year. Unfortunately, as the scale up of the programme
started in August 2009, the time frame available for
comparison is limited to the initial months of scale-up.
Other than HMM, the same malaria control strategies
were implemented both in intervention and control areas.Table 2 Patients and case management by home-based care
Number of suspected





2009 6697 6198 2144
2010* 5885 5474 2126
TOTAL 12582 11672 4270
*Results for 2010 only through May 2010.ITN ownership and use in intervention and comparison
regions are shown in Table 1, and were slightly higher in
the comparison regions. Routine data reported from the
health facilities were used to assess the impact of the inter-
vention, by comparing morbidity and mortality reported
during 2009 to that reported in 2008, the baseline year.
The NMCP database was used to calculate the numbers
of total consultations, suspected malaria cases, confirmed
malaria cases, hospitalizations and deaths attributed to
malaria for all districts in the intervention and comparison
areas. Absolute counts were converted to incidence per
100,000 using district population. Poisson confidence
intervals were calculated for the incidence risk difference
between 2008 and 2009 in the intervention and compari-
son regions. These were then used to calculate confidence
intervals for the per cent change from 2008 to 2009.
Costs for the HMM programme were calculated, in-
cluding costs for training, non-consumable supplies, and
supervision. RDTs and ACTs were supplied by the near-
est health post and were not included in the cost calcula-
tion, on the assumption that these costs would have been
borne by the system in the absence of the programme.Ethical considerations
This intervention was driven by the Ministry of Health
according to its policy and malaria strategy. Informationproviders
sitive Number of patients
treated and cured
Number of deaths attributed to




Table 3 Reasons for patient referral by home-based care








2009 3224 41 36 76 3377
2010 3262 78 69 85 3494
TOTAL 6486 119 105 161 6871
*Results for 2010 only through May 2010.
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the implementation. Individual patient information was
not collected as part of the assessment. As a programme
implementation, Institutional Review Board clearance
was not required.Results
HCP performance
During 2009, the 408 HCPs saw 6997 patients with sus-
pected malaria, and performed RDTs in 6198 (92.5%). Of
those, 2144 (34.6%) were positive, and of those with a
positive RDT, 2061 (96.1%) were reported as treated and
cured. Most of the HCPs started reporting data after July
2009, at the beginning of the malaria transmission sea-
son, and the numbers of cases monthly in 2009 are
shown in Figure 2 to demonstrate the seasonality. From
January to May 2010, the 861 HCPs saw 5885 cases of
suspected malaria, and tested 5474 (93.0%). Of those,
2126 (38.8%) had a positive RDT, and of those with a
positive RDT, 97.1% were reported treated and cured.
No deaths were attributed to malaria in communitiesTable 4 Malaria morbidity and mortality reported by health f






























Comparison (population in 2009: 1,021,296)
Per 100,000 (2008) 32227 7428 2339
















(−28.9, -25.5)with HCPs (Table 2). In total, 92.8% (11,672/12,582) of
patients received an RDT, 36.6% (4270/11672) had a
positive RDT, and 96.6% of those (4126/4270) were
reported treated and cured. Home-based care providers
referred 3377 patients in 2009 and 3494 patients in
2010, primarily for a negative RDT indicating need for
further evaluation. Of the 4054 patients with a negative
RDT in 2009, 3224 (79.5%) were referred, and in 2010,
3262/3348 (97.4%) of patients with a negative RDT were
referred (Table 3).Malaria morbidity and mortality
The reported incidence and deaths per 100,000 popula-
tion were similar in intervention and comparison areas
in 2008. The numbers of total outpatient consultations
increased in both intervention and control regions, by
15.8% (95% CI 15.5-16.1) and 10.9% (95% CI 10.4-11.4),
respectively. Suspected malaria cases per 100,000
decreased by 26.2% (95% CI 25.6-26.8) in 2009 com-
pared to 2008 in intervention regions, and by 10.5%
(95% CI 9.5-11.5) in 2009 compared to 2008 in compari-
son regions, while confirmed cases decreased 27.2% in
both. Total and malaria-related hospitalizations
decreased similarly in intervention and comparison
regions, with total hospitalizations decreasing by 23.6%
(95% CI 21.6-25.6) and 24.7% (95% CI 21.4-28.0), re-
spectively, and malaria-related hospitalizations decreas-
ing by 43.1% (95% CI 39.6-46.6) and 40.9% (95% CI
34.6-47.3), respectively. In the intervention regions, total
deaths per 100,000 decreased 15.4% (95% CI 5.4-25.4) and
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change in total deaths or malaria related deaths was seen
in comparison regions (Table 4).
Costs
The scale-up of the programme during 2009 cost a total
of USD 163,424.61, excluding RDTs and ACT. Training
and supervision for the 408 HCPs cost USD 121,424.61,
while non-consumables cost USD 42,000.00. When
divided by the number of HCP, cost per community cov-
ered was USD 400.55. With an average community size
of approximately 500, this amounts to less than USD
1.00 per at risk person.
Discussion
The scale-up of HMM maintained the high adherence of
HCPs to case management guidelines and the absence of
malaria-attributed deaths seen in the pilot phase. HCPs
tested 93% of suspected cases in both 2009 and 2010,
and treated more than 95% of confirmed cases in both
years, with no deaths attributed to malaria, showing that
the rapid scale-up did not compromise performance. A
high proportion of patients with negative RDTs were
reported to have been referred for further evaluation.
The increase in overall consultations from 2008 to
2009, with the simultaneous decreases in suspected
and confirmed cases as well as malaria-attributed hospi-
talizations in both areas, is likely due to increased access to
health care in the setting of simultaneous scale-up of mal-
aria prevention, primarily long-lasting insecticide treated
nets (LLINs), which took place during the same period. A
nationwide LLIN distribution campaign targeting children
6–59 months was conducted in June 2009 [23].
The intervention regions experienced a statistically
significant decrease in all deaths and deaths attributed to
malaria; no such decrease was seen in comparison
regions. No other known differences in malaria manage-
ment were present between comparison and inter-
vention regions (diagnostics, treatment, supportive
interventions, and costs). This pattern is consistent with
an intervention such as improved access to case man-
agement that, while not having an impact on number of
cases in the short term, prevents progression to severe
disease and death. While there was not a relative de-
crease in hospitalizations, the HCPs also facilitated
timely referral of severe cases, which may have enabled
those patients to receive inpatient care while in relatively
good condition. While not proof of a causal relationship,
it is plausible that a large proportion of deaths are due
to severe disease in those who have difficult access to
health care and thus have long delays in seeking care,
and that home-based diagnosis and treatment for these
remote populations prevents the progression of uncom-
plicated malaria to severe disease and death.While costs were not formally measured, at a cost of
less than $1 per person at risk, programme cost was rea-
sonable. A formal cost-effectiveness analysis of HMM
has found it a cost-effective strategy, even when not tak-
ing into account the decreased expenses for the users
[24]. The cost-effectiveness of HMM would be increased
by expanding the services provided by HCPs to include
management of diarrhoea and pneumonia, further de-
creasing the numbers of patients requiring health facility
referral. Other roles for home-based care providers
have been explored, such as combining home-based
management with intermittent preventive treatment in
children [25-28].
This analysis faces a number of limitations. In a re-
search setting, one would pre-define and possibly
randomize intervention and control areas, and record a
great deal more information. In a large-scale implemen-
tation in the majority of the regions of the country, this
is not feasible, thus analysis of a limited set of program-
matic data is necessary. Proving causality is not possible,
but sources are triangulated to arrive at an argument for
the plausibility of the impact. Data reported by the HCPs
are subject to bias as they may inflate their performance,
although all data reported by the HCPs were required to
be verified by the health post nurse. Data reported by
health facilities does not capture those not treated by
the public health sector. Only deaths that occurred in
public health facilities are measured; deaths occurring at
private health facilities, at home or prior to arrival can-
not be measured by this method. While a shift of deaths
away from public health facilities in the intervention
regions is possible, the increase in outpatient consulta-
tions in both regions, as well as the identical decrease in
hospitalizations in the intervention and comparison
regions argues against this. Analysis of impact is limited
to the malaria transmission season of 2009, when the
intervention was being scaled-up, which likely decreases
impact measured. In addition, the implementation was
limited to a subset of the most remote communities,
and did not cover the entire population for which dis-
trict level data was reported, possibly further diluting the
impact. Given the simultaneous scale-up of other mal-
aria control interventions, the amount of impact is im-
possible to measure due to the inability to firmly
attribute decreases to the HMM programme. Nonethe-
less, it appears that the implementation of HMM is
likely to have been at least partially responsible for the
decrease in deaths attributed to malaria in the regions in
which it was implemented.
Conclusion
Rapid scale-up of home-based management of malaria
in Senegal demonstrated continued excellent adherence
of home care providers in appropriate management
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treatment with ACT. The goal of the HMM
programme is to continue the scale up to reach 2000
remote communities. In the interim, ACT has been
offered free of charge in the public sector since May
2010, and plans have been made to train HCPs to man-
age diarrhoea and pneumonia. As an increasing pro-
portion of febrile cases are managed in the community,
provision of diagnosis-based case management at the
community level is imperative in order to measure
achievements in malaria control and provide adequate
disease surveillance.
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